Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease”

75 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 75 results

Not applicableLooking for participantsNCT06618807
What this trial is testing

Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Unity Health Toronto 60
Early research (Phase 1)Not Yet RecruitingNCT07489599
What this trial is testing

QLH2405 in Healthy Participants and Participants With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease(AD)Mild Cognitive Impairment (MCI)
Qilu Pharmaceutical Co., Ltd. 68
Very early researchActive Not RecruitingNCT04075435
What this trial is testing

Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia

Who this might be right for
Alzheimer DiseaseAnxietyAgitation,Psychomotor+1 more
Mclean Hospital 12
Testing effectiveness (Phase 2)Study completedNCT05619692
What this trial is testing

Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Who this might be right for
Mild Cognitive ImpairmentMild DementiaAlzheimer's Disease
Supernus Pharmaceuticals, Inc. 174
Not applicableActive Not RecruitingNCT02951598
What this trial is testing

Health Care Use and Costs in Participants With Early Stage Alzheimer's Disease (AD)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Eli Lilly and Company 1,400
Large-scale testing (Phase 3)Looking for participantsNCT07170150
What this trial is testing

A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimers Disease
Hoffmann-La Roche 800
Large-scale testing (Phase 3)Ended earlyNCT01931566
What this trial is testing

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset

Who this might be right for
Mild Cognitive Impairment Due to Alzheimer's Disease
Takeda 3,494
Testing effectiveness (Phase 2)Looking for participantsNCT07027072
What this trial is testing

Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd 114
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Large-scale testing (Phase 3)Study completedNCT05542953
What this trial is testing

[18F]APN-1607 PET in Subjects With AD Compared to HC

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment Due to Alzheimer's DiseaseHealthy Volunteers
APRINOIA Therapeutics 230
Large-scale testing (Phase 3)Study completedNCT03721705
What this trial is testing

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more
Renew Research, LLC 190
Not applicableEnrolling By InvitationNCT06379594
What this trial is testing

UK Based Remote Brain Health Clinic (BHC) for Patients With Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive ImpairmentMild Cognitive Impairment Due to Alzheimer's Disease
South London and Maudsley NHS Foundation Trust 200
Early research (Phase 1)Study completedNCT03019536
What this trial is testing

LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 22
Not applicableLooking for participantsNCT06400368
What this trial is testing

Effect of LEQEMBI on Cerebral and Retinal Amyloid in Mild Cognitive Impairment Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive ImpairmentAlzheimer Disease
NeuroVision Imaging 200
Testing effectiveness (Phase 2)Study completedNCT04032626
What this trial is testing

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Who this might be right for
Cognitive Impairment, MildCognitive DysfunctionAmyloid Plaque+2 more
St. Joseph's Hospital and Medical Center, Phoenix 15
Early research (Phase 1)Study completedNCT06114745
What this trial is testing

A Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)
Atridia Pty Ltd. 2
Early research (Phase 1)Ended earlyNCT02614131
What this trial is testing

LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)

Who this might be right for
HealthyAlzheimer's DiseaseMild Cognitive Impairment
Eli Lilly and Company 50
Not applicableUnknownNCT03672279
What this trial is testing

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease

Who this might be right for
Dementia AlzheimersMild Cognitive ImpairmentCognition Disorders+1 more
University Hospital, Basel, Switzerland 100
Testing effectiveness (Phase 2)Study completedNCT02707458
What this trial is testing

Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

Who this might be right for
Dementia of the Alzheimer TypeAge-related Cognitive DeclineMild Cognitive Impairment Due to Alzheimer Disease
Douglas Mental Health University Institute 23
Early research (Phase 1)Study completedNCT02624778
What this trial is testing

LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD

Who this might be right for
Alzheimer Disease
Eli Lilly and Company 61
Load More Results